Results 271 to 280 of about 212,484 (305)
Some of the next articles are maybe not open access.
Progestagens for endometrial cancer
1999Progestagen therapy following primary surgery for endometrial cancer has been advocated to reduce the risk of recurrence. The objective of this review was to assess the effect of adjuvant progestagen therapy in endometrial cancer.We searched the Cochrane Gynaecological Cancer Group trials register and MEDLINE up to May 1999.Randomised trials of ...
L, Martin-Hirsch P +3 more
openaire +2 more sources
Immunomodulation in Endometrial Cancer
International Journal of Gynecological Cancer, 2009Endometrial cancer is the most frequent gynecological cancer and the fourth most common cancer in women in the developed world. Over the last decade, immunotherapy has been the focus of intense investigation as a form of cancer treatment whereby the treatment initiates a host immune response ultimately eradicating the tumor.
Nicole, Brooks, Dodie S, Pouniotis
openaire +2 more sources
Management of endometrial cancer
European Journal of Surgical Oncology (EJSO), 2006To review broadly the diagnosis and treatment of endometrial cancer, concentrating on the evidence base.The peer reviewed literature has been cited selectively to support the principal themes of the review.A rising incidence of endometrial cancer will continue to present challenges to improve survival particularly for high-risk and advanced disease ...
openaire +2 more sources
Epidemiology of endometrial cancer
1989The incidence of endometrial cancer rose sharply in the United States in the early 1970s, paralleling changes in the use of postmenopausal estrogens by American women. A sizable body of evidence supports the role of both excessive endogenous estrogen and exogenous estrogen in the etiology of endometrial cancer.
L F, Voigt, N S, Weiss
openaire +2 more sources
Endometrial cancer and fertility
Current Opinion in Obstetrics & Gynecology, 2006Endometrial cancer can affect reproductive-age women who may desire fertility preservation. This article discusses the current, available data about conservative management of endometrial cancer in young women.Reproductive-age women with well differentiated endometrial carcinoma have an overall favorable prognosis provided that the tumor is identified ...
Beth W, Rackow, Aydin, Arici
openaire +2 more sources
Pharmacotherapy of endometrial cancer
Expert Opinion on Pharmacotherapy, 2009Endometrial cancer is the seventh most common malignancy among women worldwide. Despite most cases being diagnosed at an early stage, the death rate has increased steadily over the past 20 years. The lack of an effective, standardized adjuvant treatment for women at a high risk of recurrence has contributed to these disappointing results.The goal of ...
Nicanor I, Barrena Medel +4 more
openaire +2 more sources
Estrogens and Endometrial Cancer
Journal of Urology, 1980The role of ovarian hormones in endometrial carcinoma was first suspected on the basis of observations of certain endocrine disorders, e.g. polycystic ovary syndrome and hormone secreting ovarian tumors1,2. Recently postmenopausal estrogen therapy became the center of controversy on possible endometrial carcinogenicity3–50.
J L, Ambrus +8 more
openaire +2 more sources
Prevention of Endometrial Cancer
JAMA: The Journal of the American Medical Association, 1977To the Editor.— It was a welcome relief to read Lipsett's article, "Estrogen Use and Cancer Risk" (237:1112), in which he supports the thesis that estrogens per se are not carcinogenic but are "preparative" for the development of cancer. There is little doubt that the cause of endometrial cancer is some carcinogenic agent (a virus or some other ...
openaire +2 more sources
Screening for endometrial cancer
Medical Journal of Australia, 2003Routine screening for endometrial carcinoma is currently not justified. Postmenopausal women need to be educated about the importance of seeking attention if any vaginal bleeding occurs. All postmenopausal bleeding requires review and appropriate investigation.
openaire +2 more sources

